Current concepts. Neuroleptic malignant syndrome.
D000547:Amantadine / Q000627:therapeutic use; D001480:Basal Ganglia Diseases / Q000175:diagnosis / Q000188:drug therapy; D001971:Bromocriptine / Q000627:therapeutic use; D002389:Catatonia / Q000175:diagnosis; D003620:Dantrolene / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004347:Drug Interactions; D006359:Heat Exhaustion / Q000175:diagnosis; D006801:Humans; D008305:Malignant Hyperthermia / Q000175:diagnosis; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis / Q000188:drug therapy; D010276:Parasympatholytics / Q000009:adverse effects
D008996:Monoamine Oxidase Inhibitors; D010276:Parasympatholytics; D001971:Bromocriptine; D000547:Amantadine; D003620:Dantrolene